A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

Clinical trial NCT05596422 · COMPLETED

Trial details

NCT number: NCT05596422
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Disease (IBD)Ulcerative Colitis Crohn's Disease

Start date: 2021-05-27
Primary completion: 2022-10-27
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.